Company: APXIF
Filing Date: 2025-06-11
Form Type: 10-Q
Source: 0001213900-25-053185
Chunk: 156

Company: APx Acquisition Corp. I
Filing Date: 2025-06-11
Form: 10-Q
Item: Part I, Item 2
Chunk 156
---
 MultiplAI SPA is terminated, no more than 30,000,000 issued and outstanding Company Shares (on a fully
diluted after consummation of the Restructuring), in addition to any Company Shares issued pursuant to any PIPE Subscription Agreements
and the Backstop Agreement.

The obligations of OmnigenicsAI
and Merger Sub to consummate the Proposed Business Combination are subject to certain additional conditions at or prior to the Closing,
including (a) the accuracy of certain representations and warranties of the Company except, with respect to certain representations
and warranties, where the failure of such representations and warranties to be true and correct does not result in a SPAC Material Adverse
Effect; (b) the performance or compliance in all material respects with all agreements and covenants required by the Proposed Business
Combination Agreement; and (c) the absence of a SPAC Material Adverse Effect.

 33

While the obligation
of MultiplAI to consummate the Proposed Business Combination is subject to the consummation of the transactions contemplated by the MultiplAI
SPA, the obligations of the parties to the Business Combination Agreement (other than MultiplAI) to consummate the Proposed Business Combination
is not subject to the consummation of the transactions contemplated by the MultiplAI SPA.

Representations and Warranties

The Business Combination
Agreement contains customary representations and warranties of the Company, OmnigenicsAI, MultiplAI and Merger Sub relating to, among
other things, their ability to enter into the Business Combination Agreement and the other Transaction Documents to which they are party
and their outstanding capitalization. The representations and warranties of the parties contained in the Business Combination Agreement
will terminate and be of no further force and effect as of the Closing.

Covenants

The Business
Combination Agreement contains customary covenants of the parties, including, among others, covenants providing for (i) the
operation of the parties’ respective businesses prior to consummation of the Business Combination, (ii) the
parties’ efforts to satisfy conditions to consummate the Business Combination, (iii) the parties’ preparing and
OmnigenicsAI filing a registration statement containing a proxy statement/prospectus for the purpose of soliciting proxies from the
Company’s shareholders to vote in favor of certain matters and registering under the Securities Act of 1933, as amended (the
“Securities Act”) the Company Shares and Company W